Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
10/2002
10/22/2002US6468406 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
10/17/2002WO2002081428A1 Benzene compound and salt thereof
10/17/2002WO2002081078A2 Solid phase synthesis supports and methods
10/17/2002WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002WO2002048164A3 Isolation of nucleic acids
10/17/2002WO2002000920A3 Ingestibles possessing intrinsic color change
10/17/2002US20020151750 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide
10/17/2002US20020151735 Such as (S)-ps-ortho-Bis(bis(dimethylamino)phosphino)-(2.2)-p-cyclophane; useful as chemical intermediates for transition metal-catalysed asymmetric hydrogenation reactions
10/17/2002US20020150545 Copper sulfat complexes to amino acid
10/16/2002EP0920434B1 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
10/16/2002EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002CN1092630C Process for alkoxylation of fluorinated alcohols
10/15/2002US6465692 Reagents for preparing a sample containing biomolecular analytes for capillary electrophoretic separation and methods for making the reagents
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002US6465594 Phosphine derivative and polymer thereof and transition metal complex comprising the same
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465221 Method of producing a taxane-type diterpene
10/10/2002WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002WO2002079142A1 A process for the production of amides from amines
10/10/2002WO2002079137A1 Interleukin-1 and tumor necrosis factor-alpha modulators and their enantiomers, their synthesis and use
10/10/2002WO2002036546A3 Alkynyl amides and their therapeutic applications
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147335 Anticancer, antitumor agents
10/10/2002US20020147230 Cardiovascular disorders; antihistamines
10/10/2002US20020147204 Amide derivative
10/10/2002US20020147191 Antiinflammatory agents, psychological disorders
10/10/2002US20020146473 High temperature solvent extraction of echinacea plant extracts; drying to form powders, then compressing with excipients to form tablets; efficiency
10/10/2002US20020144360 Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors
10/10/2002CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002EP0679082B1 C10 taxane derivatives and pharmaceutical compositions
10/09/2002CN1373783A Polyalkoxylated superamides optionally functionalised, use as emulsifiers
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002CN1092182C Process for preparation of contrast agent
10/08/2002US6462234 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide
10/08/2002US6462226 Reduction of 4-amino-5-azido shikimic acid derivatives with a phosphine in the presence of a carboxylic acid without formation of ?2-azido-5-amino? intermediate which has shown to be ?ames positive?
10/08/2002US6462208 C7 acyloxy and hydrido taxane derivatives and pharmaceutical compositions containing them
10/08/2002US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia,
10/08/2002US6462179 Conjugation to peptides, proteins, hormones, polysaccharides, nucleic acids, haptens, drugs, ligands, toxins, halophors, and other macromolecules
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide
10/08/2002US6461642 Crystallization using supercritical or subcritical fluids
10/08/2002US6461598 Ethoxylated quaternary ammonium compound
10/08/2002CA2058328C 2-aryl-5-trifluoromethyl)-2-pyrroline compounds useful in the manufacture of insecticidal, nematocidal and acaricidal arylpyrroles
10/03/2002WO2002077074A1 Compounds for a controlled release of active compounds
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076928A2 Alkylamine derivatives as antifouling agents
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076923A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92
10/03/2002US20020142924 Dialkyl quats
10/03/2002CA2443289A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002CA2441197A1 Alkylamine derivatives as antifouling agents
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1245558A1 Alkylamine derivates as anti-fouling agents
10/02/2002EP1244437A1 Tertiary amino compounds having opioid receptor affinity
10/02/2002EP0915832B1 Boronic compound complexing reagents and highly stable complexes
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
10/02/2002EP0690853B1 Taxanes prepared by beta-lactams and ammonium alkoxides
10/02/2002CN1372561A Synthese of substitutd pyrazolopyrimidines
10/02/2002CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection
10/01/2002US6458977 Taxane derivatives as anticarcinogenic or antitumor agents
10/01/2002US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives
10/01/2002US6458953 Valency platform molecules comprising carbamate linkages
10/01/2002US6458948 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458806 Aryl alkenamides derivatives as MCP-1 antagonists
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458337 Diagnostic imaging contrast agent with improved in serum relaxivity
09/2002
09/26/2002WO2002074737A2 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols
09/26/2002WO2002074729A2 Quaternary surfactants
09/26/2002WO2002057201A3 Polymerizable higher diamondoid derivatives
09/26/2002WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/26/2002WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand
09/26/2002US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002US20020137936 Reacting anisidine with 3-chloropropionamide to form N-(4-methoxy phenyl)-3-chloropropionamide; intramolecular Friedel-Crafts cyclization with a Lewis acid; decomposition of salt; demethylation
09/26/2002US20020137855 Universal supports for oligonucleotide synthesis
09/26/2002US20020137775 Novel delta dicarbonyl compounds and methods for using the same
09/26/2002DE10114084A1 New 1,3-diamino-4-aminomethyl-benzene derivatives, useful as coupler substances in oxidative hair dye formulations based on a developer-coupler combination
09/26/2002DE10113334A1 Novel quaternary surfactants, with amphoteric betaine or cationic quaternary amide structure, are useful in cosmetic, pharmaceutical, detergent, rinsing or revivifying compositions and have good storage stability
09/25/2002EP1243577A1 Novel phenylalanine derivatives
09/25/2002EP1242364A1 Adamantane derivatives
09/25/2002EP1242363A2 Cd45 inhibitors
09/25/2002EP0912492B1 Method for preparing halogenated 2-amino or 2-acetamido trifluoromethylbenzene derivatives
09/25/2002CN1091446C Colchicine derivatives, use thereof and formulations containing them
09/24/2002US6455737 Cationic dyes and oxidation bases having intense shades or colors and colorfastness used on human keratin fibers such as hair; multicompartment kits
09/24/2002US6455715 Method of producing dicarboxylic acids suitable for synthesis of polymers or polyamides
09/24/2002US6455585 Have a higher analgesic activity, a lower toxicity and a longer effective time period than tramadol.
09/24/2002US6455550 N-alkanoylphenylalanine derivatives
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/24/2002US6455464 Preparation and use of non-chrome catalysts for Cu/Cr catalyst applications
09/19/2002WO2002072559A1 Process to intermediates for biologically active compounds